A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: indicative (22), suggestive (83)

Cyclophosphamide-Epirubicin (100)-Fluorouracil (FE100C)

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100C) • Breast Canc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE100C.pdf

Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO)

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE (PO)-FLUOROURACIL-METHOTREXATE (CMF-PO) Regimen • Breast Canc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-PO.pdf

Cyclophosphamide (IV)-Fluorouracil-Methotrexate (CMF IV)

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE–FLUOROURACIL-METHOTREXATE (CMF IV) Regimen • Breast Cancer –
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-IV.pdf

Lomustine-Procarbazine-Vincristine (PCV) ver 1.1

Description
Chemotherapy Protocol Central Nervous System LOMUSTINE-PROCARBAZINE-VINCRISTINE (PCV) Regimen CNS – Lomustine-Procarbazine-Vincristine (PCV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-Vincristine-PCV-ver-1.1.pdf

Child protection and safeguarding - patient information

Description
Child protection and safeguarding Information for parents, carers and guardians Child protection at Southampton Children’s Ho
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Child-protection-and-safeguarding-2197-PIL.pdf

DA_3+8_CADD

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA Ambulatory Regimen AmB - DA (3+8) CADD–Cytarabine-Daunorubicin Regimen • Acute Myeloid Leukaemia – AmB - DA (3+8) CADD – Cy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8-CADD.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol BREAST CANCER PACLITAXEL (7 day) Regimen • Breast Cancer – Paclitaxel (7 day) Indication • Treatment of locally a
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-7-day.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER PACLITAXEL (7 day) Regimen • Ovary – Paclitaxel (7 day) Indication • Second or subsequent line treatment of plati
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Paclitaxel-7-day.pdf

Liposomal doxorubicin

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER LIPOSOMAL DOXORUBICIN (Caelyx) Please note this protocol is based on information for the use of the Caelyx brand of liposom
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Liposomaldoxorubicin.pdf

Irinotecan Mitomycin

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER IRINOTECAN-MITOMYCIN Regimen Ovary-Irinotecan-Mitomycin Indication Platinum refractory clear cell or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/IrinotecanMitomycin.pdf
271 to 280 of 527
Previous … 26 27 28 29 30 … Next